During the past decade, Centro Cardiovascular Colombiano Clínica Santa María conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro Cardiovascular Colombiano Clínica Santa María" are "Chronic Thromboembolic Pulmonary Hypertension" (1 trials) and "Pulmonary Arterial Hypertension" (1 trials). Many other conditions were trialed in "Centro Cardiovascular Colombiano Clínica Santa María" in a lesser frequency.

Most popular intervention types in "Centro Cardiovascular Colombiano Clínica Santa María" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Macitentan" (1 trials), "Macitentan 10 mg" (1 trials), "Macitentan 37.5 mg" (1 trials) and "Macitentan 75 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Cardiovascular Colombiano Clínica Santa María" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centro Cardiovascular Colombiano Clínica Santa María". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centro Cardiovascular Colombiano Clínica Santa María, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro Cardiovascular Colombiano Clínica Santa María, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".